ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's International, Phase III Clinical Study prnasia
April 27, 2020On April 8, 2020, Shanghai?Green Valley Pharmaceuticals, China received the formal?decision letter from the US Food and Drug Administration (FDA)?on the Investigational New Drug (IND) application for the GV-971 international multi-center?Phase III clinica
Pharma Sources Insight January 2025
